Minimal residual disease in acute myelogenous leukemia with PML/RARα or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow

Leukemia and Lymphoma

Volumn 29, Issue 5-6, 1998, Pages 553-561

  Inokuchi, Koiti ^a   Iwakiri, Rika ^a   Futaki, Makoto ^a   Hanawa, Hideki ^a   Tanosaki, Sakae ^a   Nomura, Takeo ^a   Dan, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

AML1 ETO; Minimal residual disease; Natural killer cells; PML RAR ; T cells

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LYMPHOCYTE SUBPOPULATION; MINIMAL RESIDUAL DISEASE; NATURAL KILLER CELL; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0031837836     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050915     Document Type: Article

References (34)

1. Campana, D. and Pui, C-H. (1995). Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood, 85, 1416-1434.
2. Radicn, J. P., Gehly, G., Gooley, T., Bryant, E., Clift, R. A., Collins, S., Edmands, S., Kirk, J., Lee, A., Kessler, P., Schoch, G., Buckner, C. D., Sullivan, K. M., Appelbaum, F. R. and Thomas, E. D. (1995). Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood, 85, 2632-2638.
3. Kusec, R., Laczika, K., Knobl, P., Friedl, J., Greinix, H., Kahls, P., Linkesch, W., Schwarzinger, I., Mitterbauer, G., Putscher, B., Haas, O. A., Lechner, K. and Jaeger, U. (1994). AML/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after transplantation. Leukemia, 8, 735-739.
4. Pignon, J. M., Hennis, T., Amslsm, S., Vidaud, M., Duquesnoy, P., Vemant, J. P., Kuentz, M., Cordonnier, C., Rochant, H. and Goossens, M. (1990). Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia, 4, 83-86.
5. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Kiyoi, H., Miyawaki, S., Morishita, H., Sano, F., Kamibayashi, H., Matsue, K., Miyake, T., Hasegawa, S., Ueda, Y., Kato, Y., Kobayashi, H., Shimazaki, C., Kobayashi, M., Kurane, R., Sakota, H. and the Leukemia Study Group of the Ministry of Health and Welfare. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. Leukemia, 9, 588-593.
6. Miller, W. H., Jr., Levine, K., DeBlasio, A., Frankel, S. R., Dmistrovsky, E. and Warrell, R. P., Jr. (1993). Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA. Blood, 82, 1689-1694.
7. Delfau, M-H., Kerckaert, J-P., d'Hooghe, M. C., Fenaux, P., Lai, J-L., Jouet, J-P. and Grandchamp, B. (1990). Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia, 4, 1-5.
8. Ito, Y., Wasserman, R., Galili, N., Reichard, B. A., Shane, S., Lange, B. and Rovera, G. (1993). Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. Journal of Clinical Oncology, 11, 546-553.
9. Guerrasio, A., Rosso, C., Martinelli, G., LoCoco, F., Pampinella, M., Santoro, A., Lanza, C., Allione, B., Resegotti, L. and Saglio, G. (1995). Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukemia in contineous clinical remission. British Journal of Haematology, 90, 364-368.
10. Huang, W., Sun, G-L., Li, X-S., Cao, Q., Lu, Y., Jang, G-S., Zhang, F-Q., Chai, J-R., Wang, Z., Waxman, S., Chen, Z. and Chen, S-J. (1993). Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood, 82, 1264-1269.
11. Adler, A., Albo, V., Blatt, J, Whiteside, T. L. and Herberman, R. B. (1989). Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission. Blood, 74, 1690-1697.
12. Yoda, Y., Abe, T., Tashiro, A., Hirosawa, S., Kawada, K., Onozawa, Y., Adachi, Y., Shishido, H. and Nomura, T. (1983). Normalized natural Killer (NK) cell activity in long-term remission of acute leukaemia. British Journal of Haematology, 55, 305-309.
13. Adler, A., Chervenick, P. A., Whiteside, T. L., Lotzova, E. and Herberman, R. B. (1988). Interleukein 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Blood, 71, 709-716.
14. Bennett, J. M., Catvsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1976). Proposals for the classification of the acute leukemia. French-American-British (FAB) Cooperative Group. British Journal of Haematology, 33, 451-458.
15. Yokose, N., Ogata, K., Ito, T., Miyake, K., An, E., Inokuchi, K., Yamada, T., Gomi, S., Tanabe, Y., Ohki, I., Kuwabara, T., Hasegawa, S., Shinohara, T., Dan, K. and Nomura, T. (1993). Chemotherapy for minimally differentiated acute myeloid leukemia (AML-MO). Annals of Hematology, 66, 67-70.
16. Iwakiri, R., Inokuchi, K., Dan, K. and Nomura, T. (1994). Marked basophilia in acute promyelocytic lekaemia treated with all-trans retinoic acid: molecular analysis of the cell origin of the basophils. British Journal of Haematology, 86, 870-872.
17. Miyake, K., Inokuchi, K., Dan, K. and Nomura, T. (1993). Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood, 82, 927-930.
18. Kozu, T., Miyoshi, H., Shimizu, K., Maseki, N., Kaneko, Y., Asou, H., Kamada, N. and Ohki, M. (1993). Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood, 82, 1270-1276.
19. Abo, J., Inokuchi, K., Dan, K. and Nomura, T. (1993). p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Blood, 82, 2829-2836.
20. Tobal, K., John, A. and Liu, Y. (1995). Detection of persistent PML-RARα positive cells in long term remission of acute promyelocytic leukemia (APL) by a sensitive 'hot-start' RT-PCR. British Journal of Haematology, 89 (Sup 1), 59A.
21. Lo Coco, F., Diverio, D., Pandolfi, P. P., Biondi, A., Rossi, V., Avisati, G., Rambaldi, A., Arcese, W., Petti, M. C., Meloni, F., Masera, G., Barbui, T. and Pelicci, P. G. (1992). Molecular evaluation of residual disease as predictor of relapse in acute promyelocytic leukemia. Lancet, 340, 1437-1438.
22. Diverio, D., Pandolfi, P. P., Biondi, A., Avvisati, G., Petti, M. C., Mandelli, F., Pelicci, P. G. and Lo Coco, F. (1993). Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood, 82, 3556-3559.
23. Nucifora, G., Larson, R. A. and Rowley, J. D. (1993). Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
24. Nizet, Y., Daele, S. V., Lewalle, P., Vaerman, J. L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J. L. and Martiat, P. (1993). Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogenic IgH probes and the polymerase chain reaction. Blood, 82, 1618-1625.
25. Mitterbauer, G., Fodinger, M., Scherrer, R., Knobl, P., Jaeger, U., Laczika, K., Schwarzinger, I., Gaiger, A., Geissler, K., Greinix, H., Kalhs, P., Linkesch, W., Lechner, K. and Mannhalter, C. (1995). PCR-monitoring of minimal residual leukemia after conventional chemotherapy and bone marrow transplantation in bcr-abl-positive acute lymphoblastic leukemia. British Journal of Haematology, 89, 937-941.
26. Schwartzentruber, D. J., Stetler-Stevenson, M., Rosenberg, S. A. and Topalian, S. L. (1993). Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α in response to autologous tumor stimulation. Blood, 82, 1204-1211.
27. + tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Research. 50, 2363-2370.
28. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J. and Nadler, L. M. (1994). Pivotal role of the B7:CD28 pathway in transcription tolerance and tumor immunity. Blood, 84, 3261-3282.
29. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H. (1989). Comparative studies of human FcRIII-positive and negative natural killer cells. Journal of Immunology, 143, 3183-3191.
30. Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R. and Phillips, J. H. (1986). The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. Journal of Immunology, 136, 4480-4486.
31. Armitage, R. J., Goldstone, A. H., Richards, J. D. M. and Cawley, J. C. (1986). Lymphocyte function after autologous bone marrow translation (BMT): a comparison with patients treated with allogeneic BMT amd with chemotherapy. British Journal of Haematology, 63, 637-647.
32. Bhavnani, M., Morris, J. P. H. and Testa, N. G. (1989). Children in long-term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long-term cultures. British Journal of Haematology, 71, 37-41.
33. Chang, J., Beary, C. G. and Testa, N. G. (1990). Long-term bone marrow damage after chemotherapy for acute myeloid leukemia does not improve with time. British Journal of Haematology, 75, 68-72.
34. + T-cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. British Journal of Haematology, 90, 300-307.